key: cord-0944536-0qqqf6j7
authors: Patel, Darshan P.; Guo, Jingtao; Hotaling, James M.
title: The jury is still out: COVID-19 and male reproduction
date: 2020-06-11
journal: Fertil Steril
DOI: 10.1016/j.fertnstert.2020.06.013
sha: 3a2470ed01d9e87f50b2bbec9c46d28a9d3bc6d9
doc_id: 944536
cord_uid: 0qqqf6j7

nan

CoV-2 infection and required hospitalization, there was a significant negative effect on semen parameters including sperm concentration, total sperm count, and total number of progressive motility when compared to controls. This novel finding suggests that SARS-CoV-2 infection may impact spermatogenesis, in the short term, in patients with moderate symptoms associated with COVID-19. When the cohort was categorized by presence of fever as a symptom of acute COVID-19, only total motile sperm count was significantly lower in those participants with a reported fever. Sperm concentration and sperm count were trending toward being lower in participants who reported fever, but these findings were not statistically significant. It is difficult to draw more definitive conclusions given the small sample size, short follow-up, lack of semen analyses prior to SARS-CoV-2 infection, and just a single semen analyses after infection.

Additionally, these findings may be confounded by medications used to treat COVID-19 including certain anti-virals and hydroxychloroquine (three of the four subjects with moderate symptoms of COVID-19 were treated with these medications in the current study).

The current report further questions whether SARS-CoV-2 can be transmitted in the semen.

Additionally, it is one of the first reports about SARS-CoV-2 and effects on semen parameters, although there are several limitations. Larger-scale community-based testing for SARS-CoV-2 and semen analyses in both symptomatic men with a wide range of COVID-19 severity and asymptomatic men is needed before we can better understand if sexual transmission can occur and the effects of SARS-CoV-2 on semen parameters. Although the implications of sexual transmission are debatable when considering respiratory droplet transmission due to close contact in an acutely infected or recently infected individual, there are unique considerations for artificial reproductive technologies specifically intracytoplasmic sperm injection (ICSI). We do not know whether SARS-CoV-2 can be transmitted through ICSI. As many fertility centers resume treatments for infertile couples, we do not know the implications of SARS-CoV-2 on embryonic development and fetal organogenesis. Data from future studies will provide additional knowledge and direction on this rapidly evolving issue.

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Assessment of SARS-CoV-2 in human semen -a cohort study

Absence of 2019 Novel Coronavirus in Semen and Testes of COVID-19 Patients

Study of SARS-CoV-2 in semen and urine samples of a volunteer with positive naso-pharyngeal swab

No evidence of severe acute respiratory syndrome-coronavirus 2 in semen of males recovering from coronavirus disease 2019

Clinical Characteristics and Results of Semen Tests Among Men With Coronavirus Disease